Assignee
RIBOZYME PHARM INC
US·109 granted patents·18 pending applications·10,873 citations·filing 1992–2003
Top patents by PatentIndex Score
127 records- 0199US5627053A2'deoxy-2'-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1995·Granted May 6, 1997·1.5k cites·5 claims
- 0298US6362323B1Non-nucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 2000·Granted Mar 26, 2002·179 cites·7 claims
- 0398US6117657ANon-nucleotide containing enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1998·Granted Sep 12, 2000·253 cites·13 claims
- 0498US5998203AEnzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 1996·Granted Dec 7, 1999·784 cites·41 claims
- 0598US5972704AHIV nef targeted ribozymesRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·221 cites·22 claims
- 0698US5869253AMethod and reagent for inhibiting hepatitis C virus replicationRIBOZYME PHARM INC·Filed 1996·Granted Feb 9, 1999·226 cites·22 claims
- 0798US5716824A2'-O-alkylthioalkyl and 2-C-alkylthioalkyl-containing enzymatic nucleic acids (ribozymes)RIBOZYME PHARM INC·Filed 1995·Granted Feb 10, 1998·373 cites·12 claims
- 0897US6602858B2Nucleic acid catalysts comprising L-nucleotide analogsRIBOZYME PHARM INC·Filed 2001·Granted Aug 5, 2003·68 cites·23 claims
- 0997US6395713B1Compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 1998·Granted May 28, 2002·367 cites·13 claims
- 1097US6303773B1Deprotection of RNARIBOZYME PHARM INC·Filed 2000·Granted Oct 16, 2001·150 cites·20 claims
- 1197US6248878B1Nucleoside analogsRIBOZYME PHARM INC·Filed 1997·Granted Jun 19, 2001·264 cites·16 claims
- 1297US6146886ARNA polymerase III-based expression of therapeutic RNAsRIBOZYME PHARM INC·Filed 1995·Granted Nov 14, 2000·200 cites·21 claims
- 1397US5831071ASynthesis deprotection analysis and purification of RNA and ribozymesRIBOZYME PHARM INC·Filed 1997·Granted Nov 3, 1998·197 cites·2 claims
- 1497US5610054AEnzymatic RNA molecule targeted against Hepatitis C virusRIBOZYME PHARM INC·Filed 1994·Granted Mar 11, 1997·165 cites·16 claims
- 1596US6566127B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1999·Granted May 20, 2003·141 cites·5 claims
- 1696US6528640B1Synthetic ribonucleic acids with RNAse activityRIBOZYME PHARM INC·Filed 1999·Granted Mar 4, 2003·283 cites·3 claims
- 1796US6469158B1Synthesis, deprotection, analysis and purification of RNA and ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Oct 22, 2002·205 cites·17 claims
- 1896US6353098B1Synthesis, deprotection, analysis and purification of RNA and ribozymesRIBOZYME PHARM INC·Filed 1998·Granted Mar 5, 2002·191 cites·22 claims
- 1996US6346398B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1996·Granted Feb 12, 2002·245 cites·23 claims
- 2096US5804683ADeprotection of RNA with alkylamineRIBOZYME PHARM INC·Filed 1995·Granted Sep 8, 1998·235 cites·1 claims
- 2196US5631360AN-phthaloyl-protected 2'-amino-nucleoside phosphoramditesRIBOZYME PHARM INC·Filed 1995·Granted May 20, 1997·157 cites·16 claims
- 2295US6437117B1Synthesis, deprotection, analysis and purification for RNA and ribozymesRIBOZYME PHARM INC·Filed 1999·Granted Aug 20, 2002·187 cites·16 claims
- 2395US6159951A2'-O-amino-containing nucleoside analogs and polynucleotidesRIBOZYME PHARM INC·Filed 1997·Granted Dec 12, 2000·136 cites·18 claims
- 2495US5902880ARNA polymerase III-based expression of therapeutic RNAsRIBOZYME PHARM INC·Filed 1994·Granted May 11, 1999·308 cites·24 claims
- 2595US5877022ARibozymes targeted to APO(a) RNARIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·167 cites·20 claims
- 2695US5631359AHairpin ribozymesRIBOZYME PHARM INC·Filed 1994·Granted May 20, 1997·268 cites·15 claims
- 2794US6054576ADeprotection of RNARIBOZYME PHARM INC·Filed 1998·Granted Apr 25, 2000·153 cites·17 claims
- 2893US6162909ADeprotection of RNARIBOZYME PHARM INC·Filed 1999·Granted Dec 19, 2000·130 cites·19 claims
- 2993US5646042AC-myb targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Jul 8, 1997·123 cites·220 claims
- 3092US6251666B1Nucleic acid catalysts comprising L-nucleotide analogsRIBOZYME PHARM INC·Filed 1998·Granted Jun 26, 2001·121 cites·30 claims
- 3192US5583020APermeability enhancers for negatively charged polynucleotidesRIBOZYME PHARM INC·Filed 1993·Granted Dec 10, 1996·318 cites·30 claims
- 3291US6127173ANucleic acid catalysts with endonuclease activityRIBOZYME PHARM INC·Filed 1998·Granted Oct 3, 2000·194 cites·28 claims
- 3391US5891683ANon-nucleotide containing enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1994·Granted Apr 6, 1999·104 cites·16 claims
- 3491US5877021AB7-1 targeted ribozymesRIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·88 cites·11 claims
- 3590US5985621A2'-deoxy-2'-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1996·Granted Nov 16, 1999·63 cites·12 claims
- 3690US5891684ABase-modified enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1994·Granted Apr 6, 1999·91 cites·38 claims
- 3789US5525468AAssay for Ribozyme target siteRIBOZYME PHARM INC·Filed 1994·Granted Jun 11, 1996·122 cites·15 claims
- 3887US6350934B1Nucleic acid encoding delta-9 desaturaseRIBOZYME PHARM INC·Filed 1996·Granted Feb 26, 2002·89 cites·11 claims
- 3987US6183959B1Method for target site selection and discoveryRIBOZYME PHARM INC·Filed 1998·Granted Feb 6, 2001·57 cites·48 claims
- 4087US5811300ATNF-α ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Sep 22, 1998·95 cites·13 claims
- 4186US5972699AMethod and reagent for inhibiting herpes simplex virus replicationRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·53 cites·21 claims
- 4286US5496698AMethod of isolating ribozyme targetsRIBOZYME PHARM INC·Filed 1992·Granted Mar 5, 1996·132 cites·18 claims
- 4385US6410224B1Ribozyme treatment of diseases or conditions related to levels of NF-κBRIBOZYME PHARM INC·Filed 1996·Granted Jun 25, 2002·48 cites·4 claims
- 4485US6017756AMethod and reagent for inhibiting hepatitis B virus replicationRIBOZYME PHARM INC·Filed 1994·Granted Jan 25, 2000·79 cites·6 claims
- 4585US5731295AMethod of reducing stromelysin RNA via ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Mar 24, 1998·59 cites·2 claims
- 4685US5693535AHIV targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Dec 2, 1997·84 cites·100 claims
- 4784US5989906AMethod and reagent for inhibiting P-glycoprotein (mdr-1-gene)RIBOZYME PHARM INC·Filed 1994·Granted Nov 23, 1999·62 cites·6 claims
- 4884US5861288ACatalytic DNARIBOZYME PHARM INC·Filed 1993·Granted Jan 19, 1999·87 cites·15 claims
- 4983US6586238B1Enzymatic nucleic acids containing 5′-and or 3′-cap structuresRIBOZYME PHARM INC·Filed 1999·Granted Jul 1, 2003·43 cites·20 claims
- 5083US6489465B2Xylofuranosly-containing nucleoside phosphoramidites and polynucleotidesRIBOZYME PHARM INC·Filed 2001·Granted Dec 3, 2002·7 cites·20 claims
Showing the top 50 of 127 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →